IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
240,860
Share change
+1,300
Total reported value
$104,000
Price per share
$0.47
Number of holders
6
Value change
-$505
Number of buys
2
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2017

As of 31 Mar 2017, IGC Pharma, Inc. - COM NEW (IGC) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 240,860 shares. The largest 6 holders included CITADEL ADVISORS LLC, Creative Planning, PANAGORA ASSET MANAGEMENT INC, KCG HOLDINGS, INC., UBS Group AG, and LADENBURG THALMANN FINANCIAL SERVICES INC.. This page lists 6 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.